Literature DB >> 15371409

Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.

Gina L Razidlo1, Robert L Kortum, Jamie L Haferbier, Robert E Lewis.   

Abstract

Kinase suppressor of Ras (KSR) is a molecular scaffold that interacts with the components of the Raf/MEK/ERK kinase cascade and positively regulates ERK signaling. Phosphorylation of KSR1, particularly at Ser(392), is a critical regulator of KSR1 subcellular localization and ERK activation. We examined the role of phosphorylation of both Ser(392) and Thr(274) in regulating ERK activation and cell proliferation. We hypothesized that KSR1 phosphorylation is involved in generating signaling specificity through the Raf/MEK/ERK kinase cascade in response to stimulation by different growth factors. In fibroblasts, platelet-derived growth factor stimulation induces sustained ERK activation and promotes S-phase entry. Treatment with epidermal growth factor induces transient ERK activation but fails to drive cells into S phase. Mutation of Ser(392) and Thr(274) (KSR1.TVSA) promotes sustained ERK activation and cell cycle progression with either platelet-derived growth factor or epidermal growth factor treatment. KSR1(-/-) mouse embryo fibroblasts expressing KSR1.TVSA proliferate two times faster and grow to a higher density than cells expressing the same level of wild-type KSR1. In addition, KSR1.TVSA is more stable than wild-type KSR1. These data demonstrate that phosphorylation and stability of the molecular scaffold KSR1 are critical regulators of growth factor-specific responses that promote cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371409     DOI: 10.1074/jbc.M406395200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.

Authors:  M W Gramling; C M Eischen
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

2.  The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis.

Authors:  Robert L Kortum; Diane L Costanzo; Jamie Haferbier; Steven J Schreiner; Gina L Razidlo; Ming-Hoi Wu; Deanna J Volle; Toshiyuki Mori; Hiroshi Sakaue; Nina V Chaika; Oleg V Chaika; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs.

Authors:  Joseph Lin; Angus Harding; Emanuele Giurisato; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

4.  Kinase suppressor of Ras (KSR1) modulates multiple kit-ligand-dependent mast cell functions.

Authors:  Mia Chen; Sarah Burgin; Karl Staser; Yongzheng He; Xiaohong Li; Mikella Robinson; Li Jiang; Rebecca J Chan; David Ingram; D Wade Clapp
Journal:  Exp Hematol       Date:  2011-07-01       Impact factor: 3.084

5.  Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK.

Authors:  Mario R Fernandez; MaLinda D Henry; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

6.  NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b).

Authors:  Marco Garate; Ronald P C Wong; Eric I Campos; Yemin Wang; Gang Li
Journal:  EMBO Rep       Date:  2008-04-04       Impact factor: 8.807

7.  Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes.

Authors:  Aradhana Awasthi; Asanga Samarakoon; Haiyan Chu; Rajasekaran Kamalakannan; Lawrence A Quilliam; Magdalena Chrzanowska-Wodnicka; Gilbert C White; Subramaniam Malarkannan
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

8.  BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells.

Authors:  Eftychia Oikonomou; Eleni Makrodouli; Maria Evagelidou; Tobias Joyce; Lesley Probert; Alexander Pintzas
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

9.  Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.

Authors:  Emily M Horvath; Lixuan Tackett; Alicia M McCarthy; Priya Raman; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2007-12-28

10.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.